Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medicure Inc (TSE:MPH)
:MPH
Holding TSE:MPH?
Track your performance easily
Earnings Data
Report Date
Apr 16, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 20, 2018
|% Change Since: 0.00%
|Next Earnings Date:Aug 15, 2018
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance with notable improvements in net income and revenue growth for ZYPITAMAG and Marley Drug, offset by declines in AGGRASTAT revenue and a negative adjusted EBITDA. The company's strategic focus on new drug development and legal settlement income is promising, despite challenges in pricing competition and insurance coverage.Company Guidance
During the Q3 2024 earnings call for Medicure Inc., the company reported net revenue of $5.2 million, consistent with the previous quarter. The net income for the quarter was $680,000, or $0.07 per share, which marked a significant improvement compared to a loss in the prior quarter and a net income of $84,000 in Q3 2023. This improvement was largely attributed to a settlement payment of EUR 1.5 million. The call highlighted a decrease in AGGRASTAT revenue to $1.9 million due to pricing pressures from generic competition, while ZYPITAMAG and Marley Drug experienced revenue increases to $553,000 and $2.7 million, respectively. The company also reported an increase in research and development expenses to $795,000, primarily due to ongoing clinical trials for MC-1. Additionally, Medicure emphasized its strategic focuses, including maintaining AGGRASTAT sales, expanding ZYPITAMAG and Marley Drug sales, developing MC-1 for PNPO deficiency, and advancing new chemical entities with significant market potential. Despite a negative adjusted EBITDA of $467,000, the company remained debt-free, with cash reserves of approximately $4.9 million as of September 30, 2024.Net Income Improvement
The net income for Q3 2024 was $680,000 or $0.07 per share, compared to a loss in the previous quarter and a net income of $84,000 in Q3 of the previous year. This improvement was largely due to a settlement payment.
Increase in ZYPITAMAG Revenue
Net revenues from ZYPITAMAG increased to $553,000 from $398,000 in the previous year, attributed to greater utilization through insurance formularies, specifically Medicare Part D.
Growth in Marley Drug Revenue
Marley Drug's net revenue increased to $2.7 million, up from $2.2 million the prior year, driven by a change in product mix and increased sales of ZYPITAMAG.
Successful Legal Settlement
The company recorded other income of $1.9 million due to a legal settlement with its contract development and manufacturing organization.
Launch of New Drug Development Initiatives
Medicure announced the development of a novel drug related to MC-1 with significant market potential and the acquisition of patents for new chemical entities.
---
TSE:MPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:MPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 25, 2024 | C$0.90 | C$0.99 | +10.00% |
| Aug 14, 2024 | C$1.00 | C$1.04 | +4.00% |
| May 28, 2024 | C$1.03 | C$1.05 | +1.94% |
| Apr 08, 2024 | C$1.15 | C$1.08 | -6.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Medicure Inc (TSE:MPH) report earnings?
Medicure Inc (TSE:MPH) is schdueled to report earning on Apr 16, 2025, TBA Not Confirmed.
What is Medicure Inc (TSE:MPH) earnings time?
Medicure Inc (TSE:MPH) earnings time is at Apr 16, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:MPH EPS forecast?
Currently, no data Available
---